Understanding The Role of The ALDH16A1 Gene (G126133)

Target Name: ALDH16A1

NCBI ID: G126133

ALDH16A1

Other Name(s): Aldehyde dehydrogenase family 16 member A1 | Aldehyde dehydrogenase family 16 member A1 (isoform 2) | Aldehyde dehydrogenase family 16 member A1 (isoform 1) | aldehyde dehydrogenase 16 family member A1 | ALDH16A1 variant 2 | Aldehyde dehydrogenase 16 family member A1, transcript variant 2 | Aldehyde dehydrogenase 16 family member A1, transcript variant 1 | A16A1_HUMAN | ALDH16A1 variant 1

Understanding The Role of The ALDH16A1 Gene

ALDH16A1 (Aldehyde dehydrogenase family 16 member A1) is a gene that encodes a protein known as ALDH16A1. The protein is a member of the Aldehyde dehydrogenase family 16, which is a group of enzymes involved in the metabolism of aldehydes, which are molecules that contain carbonyl groups. This family of enzymes is important for many cellular processes, including the detoxification of harmful substances and the production of energy.

The ALDH16A1 gene has been identified as a potential drug target or biomarker for several reasons. First, it is located on the X chromosome, which means that it is only expressed in females. This is important because many drugs that are effective in treating diseases associated with the X chromosome, such as breast cancer and infertility, have a higher effectiveness in female patients.

Second, the ALDH16A1 gene has been shown to be involved in the production of toxic compounds, such as these that are generated during cellular processes. This is important because many diseases are caused by the production of these harmful substances, such as cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, targeting the ALDH16A1 gene could be a way to treat these diseases.

Third, the ALDH16A1 gene has been shown to be involved in the detoxification of environmental toxins, which are often found in water and soil. This is important because exposure to these toxins can cause a variety of health problems, including cancer, neurodegenerative diseases, and respiratory problems. Targeting the ALDH16A1 gene could be a way to treat these diseases.

Finally, the ALDH16A1 gene has been shown to be involved in the production of compounds that are involved in the development and progression of certain diseases. This is important because understanding the underlying mechanisms of these diseases is important for developing effective treatments. Targeting the ALDH16A1 gene could be a way to treat these diseases.

Targeting the ALDH16A1 gene

The ALDH16A1 gene has been shown to be involved in a variety of cellular processes, including the production of toxic compounds, the detoxification of environmental toxins, and the development and progression of certain diseases. Therefore, targeting this gene could be a way to treat a variety of conditions.

One potential way to target the ALDH16A1 gene is through the use of drugs that specifically interact with this gene. These drugs could be used to treat a variety of conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, drugs that inhibit the activity of the ALDH16A1 gene could be used to treat certain types of breast cancer, which is a disease that is often associated with the ALDH16A1 gene.

Another potential way to target the ALDH16A1 gene is through the use of biomarkers that are derived from this gene. These biomarkers could be used to diagnose and monitor the progression of certain diseases, such as cancer. For example, by analyzing the expression of the ALDH16A1 gene in cancer cells, researchers could identify those cells that are more likely to be sensitive to certain treatments.

Monitoring the expression of the ALDH16A1 gene

Monitoring the expression of the ALDH16A1 gene is an important step in understanding its role in cellular processes. By analyzing the expression of this gene in a variety of cellular contexts, researchers can gain insights into its function and how it contributes to the development and progression of certain diseases.

One way to monitor the expression of the ALDH16A1 gene is through the use of RNA sequencing,

Protein Name: Aldehyde Dehydrogenase 16 Family Member A1

The "ALDH16A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ALDH16A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets